Maternal Serum Alpha-Fetoprotein Screening (MSAFP)
Home / Prenatal Testing / Maternal Serum Alpha-Fetoprotein Screening (MSAFP)
MSAFP is a screening test that examines the level of alpha-fetoprotein in the mother’s blood during pregnancy. This is not a diagnostic test. It is often part of the triple screen test that assesses whether further diagnostic testing may be needed.
It is very important to remember what a screening test is before getting one performed. This will help alleviate some of the anxiety that can accompany test results.
Screening tests do not look only at results from the blood test. They compare a number of different factors (including age, ethnicity, results from blood tests, etc…) and then estimate what a person’s chances are of having an abnormality.
These tests DO NOT diagnose a problem; they only signal that further testing should be done.
Blood is drawn from veins in the mother’s arm and sent off to a laboratory for analysis. Results are usually returned between one and two weeks.
MSAFP may be performed between the 14th and 22nd weeks of pregnancy, however it seems to be most accurate during the 16th to 18th week. Your levels of AFP vary during pregnancy so accurate pregnancy dating is imperative for more reliable screening results.
All pregnant women should be offered the MSAFP screening, but it is especially recommended for:
- Women who have a family history of birth defects
- Women who are 35 years or older
- Women who used possible harmful medications or drugs during pregnancy
- Women who have diabetes
Alpha- fetoprotein(AFP) is found in both fetal serum and also amniotic fluid.
This protein is produced early in gestation by the fetal yolk sac and then later in the liver and gastrointestinal tract. The true function of AFP is unknown.
We do know that this protein’s level increases and decreases during certain weeks of pregnancy which is why accurate pregnancy dating is crucial.
The AFP test is measuring high and low levels of alpha-fetoprotein. The results are combined with the mother’s age and ethnicity in order to assess probabilities of potential genetic disorders.
High levels of AFP may suggest the developing baby has a neural tube defect such as spina bifida or anencephaly.
High levels of AFP may also suggest defects with the esophagus or a failure of your baby’s abdomen to close.However, the most common reason for elevated AFP levels is inaccurate dating of the pregnancy.
Low levels of AFP and abnormal levels of hCG and estriol may indicate the developing baby has Trisomy 21( Down syndrome), Trisomy 18 (Edwards Syndrome) or another type of chromosome abnormality.
Abnormal levels may also be a result of the following:
It is important to remember that the AFP is a screening test and not a diagnostic test. This test only notes that a mother is at risk of carrying a baby with a potential disorder.
There are approximately 25 to 50 abnormal test AFP results for every 1,000 pregnancies tested.
Of these abnormal results, only 1 in 16 to 1 in 33 will actually have a baby that has been affected with a neural tube defect or other condition.
Abnormal test results warrant additional testing for making a diagnosis.
A more conservative approach involves performing a second MSAFP or complete triple screen test followed by a high definition ultrasound.
If the testing still maintains abnormal results, a more invasive procedure such as amniocentesis may be performed.
Invasive procedures should be discussed thoroughly with your healthcare provider. It is also important to talk through further testing with you partner. Additional counseling and discussions with a counselor, social worker or minister may prove helpful.
What are the risks and side effects of MSAFP to the mother or baby?
Except for the discomfort of drawing blood, there are no risks or side effects associated with the MSAFP.
MSAFP is a routine test that is not an invasive procedure and poses no known risks to the mother or baby. The MSAFP results may warrant additional testing.
The reasons to pursue further testing or not may vary from person to person and couple to couple. Performing further testing allows you to confirm a diagnosis and then provides you with certain opportunities:
- Pursue potential medical interventions that may exist
- Begin planning for a child with special needs
- Start addressing anticipated lifestyle changes
- Identify support groups and resources
- Make a decision about carrying the child to term
Some individuals or couples may elect not to pursue further testing for various reasons:
- They are comfortable with the results no matter what the outcome is
- Because of personal, moral, or religious reasons, making a decision about carrying the child to term is not an option
- Some parents choose not to allow any testing that poses any risk of harming the developing baby
It is important to discuss the risks and benefits of further testing thoroughly with your healthcare provider. Your healthcare provider will help you evaluate if the benefits from the results could outweigh any risks from the procedure.
Triple Screen Test Also Known as Triple Test , Multiple Marker Screening and AFP Plus The triple screen test is a maternal blood screening test that…
Quad Screen Test The quad screen test is a maternal blood screening test that looks for four specific substances: AFP , hCG , Estriol, and Inhibin-A….
First Trimester Screen The First Trimester Screen is a new, optional non-invasive evaluation that combines a maternal blood screening test with an…
Getting a Urinalysis: About Urine Tests Home / Prenatal Testing / Getting a Urinalysis: About Urine Tests A urine test is a routine test used by your…
Non-invasive prenatal paternity test is the safest testing for you and baby during pregnancy. If you need to know the father of your child and are not…